Rejuvenate Bio
Develops gene therapies for age-related and chronic diseases in animals and humans
$6MStrategic
Role not disclosedCI
Connecticut Innovations
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $29M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionP2 Science
Designs and manufactures renewable specialty ingredients for personal care, fragrance, and performance materials
$23MUndisclosed
Role not disclosed